Dieras V - Search Results

1

[Fundamental and methodologic bases of therapeutic intensification].

Marty M, Extra JM, Dieras V, Espie M. Marty M, et al. Among authors: dieras v. Pathol Biol (Paris). 1989 Nov;37(9):961-4. Pathol Biol (Paris). 1989. PMID: 2608350 French. No abstract available.

2

[Contribution of cytokines in the treatment of human cancers].

Marty M, Extra JM, Dieras V. Marty M, et al. Among authors: dieras v. Pathol Biol (Paris). 1990 Oct;38(8):783-5. Pathol Biol (Paris). 1990. PMID: 1703291 French. No abstract available.

3

A review of the antitumour activity of vinorelbine in breast cancer.

Marty M, Extra JM, Dieras V, Giacchetti S, Ohana S, Espié M. Marty M, et al. Among authors: dieras v. Drugs. 1992;44 Suppl 4:29-35; discussion 66-9. doi: 10.2165/00003495-199200444-00004. Drugs. 1992. PMID: 1283848 Review.

4

5HT3-antagonist receptors: their role in drug-induced emesis.

Dieras V, Extra JM, Le Bonniec M, Madelaine I, Espie M, Marty M. Dieras V, et al. Nouv Rev Fr Hematol (1978). 1990;32(6):449-52. Nouv Rev Fr Hematol (1978). 1990. PMID: 1983228 Review.

5

[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast].

Culine S, Extra JM, Espie M, Bourstyn E, Dieras V, Giacchetti S, Maylin C, De Rocquancourt A, Morvan F, Marty M. Culine S, et al. Among authors: dieras v. Bull Cancer. 1993 Nov;80(11):994-1000. Bull Cancer. 1993. PMID: 8081037 French.

6

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.

Dieras V, Extra JM, Bellissant E, Espie M, Morvan F, Pierga JY, Mignot L, Tresca P, Marty M. Dieras V, et al. J Clin Oncol. 1996 Dec;14(12):3097-104. doi: 10.1200/JCO.1996.14.12.3097. J Clin Oncol. 1996. PMID: 8955654 Clinical Trial.

7

Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer.

Robain M, Pierga JY, Jouve M, Asselain B, Diéras V, Beuzeboc P, Palangié T, Dorval T, Extra JM, Scholl S, Pouillart P. Robain M, et al. Among authors: dieras v. Eur J Cancer. 2000 Dec;36(18):2301-12. doi: 10.1016/s0959-8049(00)00325-7. Eur J Cancer. 2000. PMID: 11094303

8

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.

Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Vincent-Salomon A, Scholl S, Extra JM, Asselain B, Pouillart P. Pierga JY, et al. Among authors: dieras v. Br J Cancer. 2000 Dec;83(11):1480-7. doi: 10.1054/bjoc.2000.1461. Br J Cancer. 2000. PMID: 11076657 Free PMC article.

9

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients.

Pierga JY, Robain M, Jouve M, Asselain B, Diéras V, Beuzeboc P, Palangié T, Dorval T, Extra JM, Scholl S, Pouillart P. Pierga JY, et al. Among authors: dieras v. Ann Oncol. 2001 Feb;12(2):231-7. doi: 10.1023/a:1008330527188. Ann Oncol. 2001. PMID: 11300330 Free article. Clinical Trial.

10

Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.

Dieras V, Marty M, Tubiana N, Corette L, Morvan F, Serin D, Mignot L, Chazard M, Garet F, Onetto N, et al. Dieras V, et al. Semin Oncol. 1995 Aug;22(4 Suppl 8):33-9. Semin Oncol. 1995. PMID: 7638640 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters